Related Experiment Videos
Human alpha atrial natriuretic peptide fermentation by using a genetically engineered yeast strain
1Research Institute of Biochemical Engineering, East China University of Science and Technology, Shanghai, China.
Chinese Journal of Biotechnology
|January 1, 1994
Summary
This study optimized recombinant yeast (Y33::YFD71-3) for atrial natriuretic peptide (ANP) production. Supplementing media with adenine and other nutrients significantly increased ANP expression to 24.8 mg/L.
Area of Science:
- Biotechnology
- Molecular Biology
- Biochemistry
Background:
- Recombinant yeast strains are crucial for producing therapeutic proteins.
- Atrial natriuretic peptide (ANP) has potential therapeutic applications.
- Optimizing culture conditions is key to maximizing protein expression.
Purpose of the Study:
- To optimize the culture medium and feeding strategy for enhanced atrial natriuretic peptide (ANP) expression in a recombinant yeast strain.
- To determine the impact of specific nutrients, such as adenine, on ANP production.
Main Methods:
- Utilized a recombinant yeast strain (Y33::YFD71-3) with a defined genotype.
- Conducted preliminary batch cultures in shaking flasks using YG medium with varying nutrient concentrations.
- Performed fed-batch cultures in a RIBE-5 fermenter with optimized feeding strategies.
Main Results:
- Preliminary cultures yielded 1-2 mg/L of ANP.
- Adenine limitation was identified as a key factor influencing ANP expression.
- Fed-batch fermentation achieved a maximum ANP concentration of 24.8 mg/L.
Conclusions:
- Optimized nutrient supplementation and fed-batch strategies significantly enhance ANP production in recombinant yeast.
- Adenine availability is a critical determinant for maximizing ANP secretion.
- This optimized process shows potential for efficient large-scale ANP manufacturing.